Characterization of human tear proteome reveals differentially abundance proteins in thyroid-associated ophthalmopathy
- PMID: 35846879
- PMCID: PMC9285480
- DOI: 10.7717/peerj.13701
Characterization of human tear proteome reveals differentially abundance proteins in thyroid-associated ophthalmopathy
Abstract
Background: Thyroid-associated ophthalmopathy (TAO) is a common orbital inflammatory disease, but the abnormal expression of proteins in tears of TAO patients has not been systematically studied. The purpose of this study is to compare and analyze the total tear protein profile of TAO patients and to provide protein cues for TAO pathogenesis.
Methods: Tear samples were isolated from 30 TAO patients with obvious ocular surface damage and 30 healthy control subjects. Tear samples from 30 individuals were mixed and divided into three sample pools. Easy nano-scale LC-MS/MS based on labeling-free quantitative technology was utilized to profile tear proteome.
Results: Here, electrospray ionization mass spectra and SDS-PAGE results confirmed the good parallelisms among samples. A total of 313 proteins were obtained from six tear pools, among them, 103 differential abundance proteins (DAPs) were identified, including 99 up-regulated DAPs (including APOA1, HV103, IGH, and Transferrin variant) and four down-regulated DAPs (including FABA, VCC1, NUCB2, and E-cadherin) in the TAO group compared with the control group. GO analysis showed that up-regulated DAPs were mainly enriched in lipid metabolism and platelet molecular function, and down-regulated DAPs were involved in binding, cell junction, and cellular process. KEGG results indicated that DAPs were involved in 117 kinds of signal transduction pathways, among which the immune-related pathway of complement and coagulation cascades had the greatest relevance.
Conclusion: In conclusion, label-free LC-MS/MS is an effective strategy for profiling tear proteins component. Our study provides proteins and pathways altered in TAO and provides protein cues for further study on the precise mechanism of TAO pathogenesis.
Keywords: Complement and coagulation cascades; Hyroid-associated ophthalmopathy; Label-free LC-MS/MS; Proteomics analysis; Tears.
© 2022 Zhou et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Tear proteomics of orbital decompression for disfiguring exophthalmos in inactive thyroid-associated ophthalmopathy.Exp Ther Med. 2020 Dec;20(6):253. doi: 10.3892/etm.2020.9383. Epub 2020 Oct 23. Exp Ther Med. 2020. PMID: 33178351 Free PMC article.
-
[Expressions of lysozyme C and lactoferrin in tears of thyroid-associated ophthalmopathy patients].Zhonghua Yi Xue Za Zhi. 2015 Mar 17;95(10):749-52. Zhonghua Yi Xue Za Zhi. 2015. PMID: 26080846 Chinese.
-
Proteomics of Tear in Inactive Thyroid-Associated Ophthalmopathy.Acta Endocrinol (Buchar). 2021 Jul-Sep;17(3):291-303. doi: 10.4183/aeb.2021.291. Acta Endocrinol (Buchar). 2021. PMID: 35342480 Free PMC article.
-
The potential of tear proteomics for diagnosis and management of orbital inflammatory disorders including Graves' ophthalmopathy.Exp Eye Res. 2021 Dec;213:108813. doi: 10.1016/j.exer.2021.108813. Epub 2021 Nov 3. Exp Eye Res. 2021. PMID: 34742692 Free PMC article. Review.
-
Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.Curr Eye Res. 2020 Nov;45(11):1325-1341. doi: 10.1080/02713683.2020.1776331. Epub 2020 Jun 21. Curr Eye Res. 2020. PMID: 32567373 Review.
Cited by
-
Multi-Omics Approaches to Discover Biomarkers of Thyroid Eye Disease: A Systematic Review.Int J Biol Sci. 2024 Nov 11;20(15):6038-6055. doi: 10.7150/ijbs.103977. eCollection 2024. Int J Biol Sci. 2024. PMID: 39664569 Free PMC article.
-
Screening of pathologically significant diagnostic biomarkers in tears of thyroid eye disease based on bioinformatic analysis and machine learning.Front Cell Dev Biol. 2024 Oct 30;12:1486170. doi: 10.3389/fcell.2024.1486170. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39544368 Free PMC article.
References
-
- Annamalai B, Parsons N, Nicholson C, Joseph K, Coughlin B, Yang X, Jones BW, Tomlinson S, Rohrer B. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration. Experimental Eye Research. 2021;207:108583. doi: 10.1016/j.exer.2021.108583. - DOI - PMC - PubMed
-
- Antonelli A, Palla R, Casarosa L, Fallahi P, Baschieri L. IgG, IgA and C3 deposits in the extra-thyroidal manifestations of autoimmune Graves’ disease: their in vitro solubilization by intravenous immunoglobulin. Clinical and Experimental Rheumatology. 1996;14(Suppl 15):S31–S35. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous